Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Complejo Asistencial Universitario de León](/img/noimage_org.png)
Complejo Asistencial Universitario de León
León, EspañaPublicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de León (12)
2023
-
Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients
Seminars in Arthritis and Rheumatism, Vol. 58
2022
-
Vogt-Koyanagi-Harada disease in Spain
European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554
2019
-
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
American Journal of Ophthalmology, Vol. 200, pp. 85-94
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
-
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review
Clinical and experimental rheumatology, Vol. 36, Núm. 4, pp. 652-657
-
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease
Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451
2016
-
Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain
Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152
2013
-
Evaluation of the IL2/IL21, IL2RA and IL2RB genetic variants influence on the endogenous non-anterior uveitis genetic predisposition
BMC Medical Genetics, Vol. 14, Núm. 1
-
No evidence of association between common autoimmunity STAT4 and IL23R risk polymorphisms and non-anterior uveitis
PLoS ONE, Vol. 8, Núm. 11
-
Two Functional Variants of IRF5 Influence the Development of Macular Edema in Patients with Non-Anterior Uveitis
PLoS ONE, Vol. 8, Núm. 10
-
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis
Mediators of Inflammation, Vol. 2013
2012
-
Treatment of refractory uveitis with adalimumab: A prospective multicenter study of 131 patients
Ophthalmology, Vol. 119, Núm. 8, pp. 1575-1581